Clinical Trials Browser

Phase 3 × Interventional × Endometrial Neoplasms × Clear all

NCT05256225 2026-05-27

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Phase 3 Recruiting

Neoplasms, Endometrial Neoplasms

NCT07198074 2026-05-27

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Phase 3 Recruiting

Endometrial Neoplasms

NCT07286331 2026-05-27

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

Phase 3 Not yet recruiting

Endometrial Neoplasms

NCT06952504 2026-05-22

TroFuse-033

Phase 3 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT06340568 2026-05-20

Fern-EC-01

Phase 3 Recruiting

Endometrial Neoplasms

NCT07044336 2026-05-20

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Phase 3 Recruiting

Neoplasm Metastasis, Uterine Neoplasms, Endometrial Neoplasms

NCT07578649 2026-05-19

Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

Phase 3 Not yet recruiting

Endometrial Neoplasms

NCT06989112 2026-05-06

DE-01

Phase 3 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Neoplasms, Endometrial Neoplasms

NCT07166094 2026-05-06

RAINFOL-03

Phase 3 Recruiting

Recurrence, Endometrial Neoplasms

NCT05173987 2026-05-05

KEYNOTE-C93

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT03914612 2026-05-04

Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

Phase 3 Active not recruiting

813 enrolled 16 charts 1 FDA

GynecologicSarcoma

Carcinosarcoma, Endometrial Neoplasms

NCT05611931 2026-04-23

XPORT-EC-042

Phase 3 Recruiting

Endometrial Neoplasms

NCT03785288 2026-04-22

Vaginal Cuff Brachytherapy Fractionation Study

Phase 3 Recruiting

Endometrial Neoplasms

NCT06746116 2026-04-16

DUoENDE

Phase 3 Active not recruiting

Endometrial Neoplasms

NCT03555422 2026-04-13

ENGOT-EN5

Phase 3 Completed

Genital Diseases, Neoplasms, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT06132958 2026-04-03

TroFuse-005

Phase 3 Active not recruiting

Endometrial Neoplasms

NCT03517449 2026-03-19

MK-3475-775

Phase 3 Completed

827 enrolled 34 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT04789694 2026-03-19

PHOCUS

Phase 3 Recruiting

Frailty, Ovarian Neoplasms, Endometrial Neoplasms

NCT07022483 2026-02-04

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Phase 3 Recruiting

Neoplasms, Endometrial Neoplasms

NCT03884101 2026-02-02

LEAP-001

Phase 3 Completed

842 enrolled 25 charts

Endometrial Neoplasms

NCT04073706 2026-01-30

ENDO-3

Phase 3 Recruiting

Uterine Neoplasms, Endometrial Neoplasms

NCT06712472 2026-01-20

RAINBO-RED

Phase 3 Recruiting

Endometrial Neoplasms

NCT06486441 2026-01-15

ASCENT-GYN-01

Phase 3 Active not recruiting

Endometrial Neoplasms

NCT04269200 2025-12-23

DUO-E

Phase 3 Active not recruiting

805 enrolled 18 charts 1 FDA

Endometrial Neoplasms

NCT05201547 2025-12-04

DOMENICA

Phase 3 Active not recruiting

Neoplasm Metastasis, Endometrial Neoplasms

NCT06007586 2025-12-04

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Phase 3 Completed

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vomiting, Endometrial Neoplasms

NCT04865289 2025-12-02

LEAP-001

Phase 3 Completed

130 enrolled 24 charts

Endometrial Neoplasms

NCT04634877 2025-06-09

KEYNOTE-B21

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT05078047 2025-06-05

MOIO

Phase 3 Recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Esophageal Squamous Cell Carcinoma, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT03603184 2025-05-09

AtTEnd

Phase 3 Completed

Neoplasms, Endometrial Neoplasms

NCT05763667 2025-04-24

Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer

Phase 3 Completed

Endometrial Hyperplasia, Pain, Postoperative, Endometrial Neoplasms

NCT06584032 2025-01-07

Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer

Phase 3 Recruiting

Endometrial Neoplasms

NCT06732635 2024-12-13

FAST-TRACK

Phase 3 Completed

Endometrial Neoplasms

NCT06475599 2024-06-27

Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer

Phase 3 Not yet recruiting

Endometrial Neoplasms

NCT01820858 2024-04-02

EC-01

Phase 3 Active not recruiting

Endometrial Neoplasms

NCT04970368 2024-01-05

Comparison of Nodal Staging in Endometrial Cancer

Phase 3 Terminated

Neoplasms, Endometrial Neoplasms

NCT05446324 2023-12-01

SENGA

Phase 3 Unknown

Endometrial Neoplasms

NCT02584478 2023-11-08

AL3818

Phase 3 Unknown

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05712941 2023-11-03

Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer

Phase 3 Withdrawn

Endometrial Neoplasms

NCT00411138 2023-10-11

PORTEC-3

Phase 3 Unknown

Endometrial Neoplasms

NCT03469674 2023-10-11

PORTEC-4a

Phase 3 Active not recruiting

Endometrial Neoplasms

NCT04792749 2023-04-13

Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer

Phase 3 Unknown

Endometrial Neoplasms

NCT02997553 2023-01-09

GASVERT

Phase 3 Completed

BreastDermatologicGastrointestinalGynecologicHead & Neck

Anus Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05524389 2022-11-23

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Phase 3 Not yet recruiting

Endometrial Neoplasms

NCT01470677 2022-07-08

Tachosil for the Prevention of Symptomatic Lymph Cysts

Phase 3 Completed

Uterine Cervical Neoplasms, Lymphocele, Neoplasms, Endometrial Neoplasms

NCT01672892 2022-06-15

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

Phase 3 Completed

289 enrolled 17 charts

Uterine Cervical Neoplasms, Postoperative Complications, Radiation Injuries, Endometrial Neoplasms

NCT00376844 2022-04-12

PORTEC-2

Phase 3 Completed

Endometrial Neoplasms

NCT00006027 2020-10-22

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer

Phase 3 Completed

Endometrial Neoplasms

NCT04237090 2020-10-12

PREMED-F1

Phase 3 Completed

BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00096408 2019-03-20

Laparoscopic Approach to Cancer of the Endometrium

Phase 3 Completed

Adenocarcinoma, Carcinoma, Neoplasms, Endometrial Neoplasms